Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

YY1 controls Eμ-3'RR DNA loop formation and immunoglobulin heavy chain class switch recombination.

Mehra P, Gerasimova T, Basu A, Jha V, Banerjee A, Sindhava V, Gray F, Berry CT, Sen R, Atchison ML.

Blood Adv. 2016 Nov 29;1(1):15-20. doi: 10.1182/bloodadvances.2016000372. No abstract available.

2.

Transcription factor YY1 can control AID-mediated mutagenesis in mice.

Zaprazna K, Basu A, Tom N, Jha V, Hodawadekar S, Radova L, Malcikova J, Tichy B, Pospisilova S, Atchison ML.

Eur J Immunol. 2018 Feb;48(2):273-282. doi: 10.1002/eji.201747065. Epub 2017 Nov 14.

PMID:
29080214
3.

YY1 Is Required for Germinal Center B Cell Development.

Banerjee A, Sindhava V, Vuyyuru R, Jha V, Hodewadekar S, Manser T, Atchison ML.

PLoS One. 2016 May 11;11(5):e0155311. doi: 10.1371/journal.pone.0155311. eCollection 2016.

4.

Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X.

Wang J, Syrett CM, Kramer MC, Basu A, Atchison ML, Anguera MC.

Proc Natl Acad Sci U S A. 2016 Apr 5;113(14):E2029-38. doi: 10.1073/pnas.1520113113. Epub 2016 Mar 21.

5.

Function of YY1 in Long-Distance DNA Interactions.

Atchison ML.

Front Immunol. 2014 Feb 10;5:45. doi: 10.3389/fimmu.2014.00045. eCollection 2014. Review.

6.

YY1 DNA binding and interaction with YAF2 is essential for Polycomb recruitment.

Basu A, Wilkinson FH, Colavita K, Fennelly C, Atchison ML.

Nucleic Acids Res. 2014 Feb;42(4):2208-23. doi: 10.1093/nar/gkt1187. Epub 2013 Nov 26.

7.

YY1 controls Igκ repertoire and B-cell development, and localizes with condensin on the Igκ locus.

Pan X, Papasani M, Hao Y, Calamito M, Wei F, Quinn Iii WJ, Basu A, Wang J, Hodawadekar S, Zaprazna K, Liu H, Shi Y, Allman D, Cancro M, Atchison ML.

EMBO J. 2013 Apr 17;32(8):1168-82. doi: 10.1038/emboj.2013.66. Epub 2013 Mar 26.

8.

Increased expression of PcG protein YY1 negatively regulates B cell development while allowing accumulation of myeloid cells and LT-HSC cells.

Pan X, Jones M, Jiang J, Zaprazna K, Yu D, Pear W, Maillard I, Atchison ML.

PLoS One. 2012;7(1):e30656. doi: 10.1371/journal.pone.0030656. Epub 2012 Jan 23.

9.

YY1 controls immunoglobulin class switch recombination and nuclear activation-induced deaminase levels.

Zaprazna K, Atchison ML.

Mol Cell Biol. 2012 Apr;32(8):1542-54. doi: 10.1128/MCB.05989-11. Epub 2012 Jan 30.

10.

A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.

Hodawadekar S, Park K, Farrar MA, Atchison ML.

J Immunol. 2012 Mar 1;188(5):2276-84. doi: 10.4049/jimmunol.1102239. Epub 2012 Jan 25.

11.

CtBP levels control intergenic transcripts, PHO/YY1 DNA binding, and PcG recruitment to DNA.

Basu A, Atchison ML.

J Cell Biochem. 2010 May;110(1):62-9. doi: 10.1002/jcb.22487.

12.

PcG recruitment by the YY1 REPO domain can be mediated by Yaf2.

Wilkinson F, Pratt H, Atchison ML.

J Cell Biochem. 2010 Feb 15;109(3):478-86. doi: 10.1002/jcb.22424.

13.

PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells.

Wei F, Zaprazna K, Wang J, Atchison ML.

Mol Cell Biol. 2009 Sep;29(17):4612-22. doi: 10.1128/MCB.00234-09. Epub 2009 Jun 29.

14.

Factors that attract veterinarians to or discourage them from research careers: a program director's perspective.

Atchison ML.

J Vet Med Educ. 2009 Spring;36(1):76-82. doi: 10.3138/jvme.36.1.76.

PMID:
19435993
15.

Veterinarians in biomedical research: building national capacity.

Buss DD, Atchison ML, Corps KN, Falkowski LB, Fox JG, Hendricks JC, Mexas AM, Rosol TJ, Stromberg BE.

J Vet Med Educ. 2009 Spring;36(1):62-9. doi: 10.3138/jvme.36.1.62.

PMID:
19435991
16.

B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.

Cozma D, Yu D, Hodawadekar S, Azvolinsky A, Grande S, Tobias JW, Metzgar MH, Paterson J, Erikson J, Marafioti T, Monroe JG, Atchison ML, Thomas-Tikhonenko A.

J Clin Invest. 2007 Sep;117(9):2602-10.

17.

Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation.

Wei F, Schöler HR, Atchison ML.

J Biol Chem. 2007 Jul 20;282(29):21551-60. Epub 2007 May 24.

18.

Polycomb recruitment to DNA in vivo by the YY1 REPO domain.

Wilkinson FH, Park K, Atchison ML.

Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19296-301. Epub 2006 Dec 8.

19.

B-Lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages.

Hodawadekar S, Yu D, Cozma D, Freedman B, Sunyer O, Atchison ML, Thomas-Tikhonenko A.

Exp Cell Res. 2007 Jan 15;313(2):331-40. Epub 2006 Oct 25.

20.
21.

Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity.

Bai Y, Srinivasan L, Perkins L, Atchison ML.

J Immunol. 2005 Oct 15;175(8):5160-9.

22.

Transient requirements of YY1 expression for PcG transcriptional repression and phenotypic rescue.

Srinivasan L, Pan X, Atchison ML.

J Cell Biochem. 2005 Nov 1;96(4):689-99.

PMID:
16052488
23.

The Ig kappa 3' enhancer is activated by gradients of chromatin accessibility and protein association.

McDevit DC, Perkins L, Atchison ML, Nikolajczyk BS.

J Immunol. 2005 Mar 1;174(5):2834-42.

24.

YY1 DNA binding and PcG recruitment requires CtBP.

Srinivasan L, Atchison ML.

Genes Dev. 2004 Nov 1;18(21):2596-601.

25.

Transcriptional regulation of the cyclooxygenase-2 gene in macrophages by PU.1.

Joo M, Park GY, Wright JG, Blackwell TS, Atchison ML, Christman JW.

J Biol Chem. 2004 Feb 20;279(8):6658-65. Epub 2003 Dec 5.

26.

Transcription factor YY1 functions as a PcG protein in vivo.

Atchison L, Ghias A, Wilkinson F, Bonini N, Atchison ML.

EMBO J. 2003 Mar 17;22(6):1347-58.

27.

Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.

Yu D, Allman D, Goldschmidt MH, Atchison ML, Monroe JG, Thomas-Tikhonenko A.

Blood. 2003 Mar 1;101(5):1950-5. Epub 2002 Oct 24.

28.
29.

Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors.

Meraro D, Hashmueli S, Koren B, Azriel A, Oumard A, Kirchhoff S, Hauser H, Nagulapalli S, Atchison ML, Levi BZ.

J Immunol. 1999 Dec 15;163(12):6468-78.

30.
32.
33.

A two-step mechanism for recruitment of Pip by PU.1.

Perkel JM, Atchison ML.

J Immunol. 1998 Jan 1;160(1):241-52.

34.

Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: the C-terminus is a principal determinant for nuclear trafficking.

McNeil S, Guo B, Stein JL, Lian JB, Bushmeyer S, Seto E, Atchison ML, Penman S, van Wijnen AJ, Stein GS.

J Cell Biochem. 1998 Mar 15;68(4):500-10.

PMID:
9493912
35.
36.

PU.1 can participate in an active enhancer complex without its transcriptional activation domain.

Pongubala JM, Atchison ML.

Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):127-32.

37.
38.

Characterization of functional domains within the multifunctional transcription factor, YY1.

Bushmeyer S, Park K, Atchison ML.

J Biol Chem. 1995 Dec 15;270(50):30213-20.

39.

Multiple proteins physically interact with PU.1. Transcriptional synergy with NF-IL6 beta (C/EBP delta, CRP3).

Nagulapalli S, Pongubala JM, Atchison ML.

J Immunol. 1995 Nov 1;155(9):4330-8.

PMID:
7594592
41.

High-resolution mapping of 10 unique DNA sequences to human chromosome 3 subregions by in situ hybridization.

Atchison L, Atchison ML, Cannizzaro LA.

Cytogenet Cell Genet. 1995;71(2):136-8.

PMID:
7656582
43.

Construction of human chromosome-3-specific radiation hybrids and characterization by Alu-PCR.

Atchison L, Comis RL, Atchison ML.

Gene. 1994 Dec 30;151(1-2):321-4.

PMID:
7828898
45.

Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation.

Pongubala JM, Van Beveren C, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML.

Science. 1993 Mar 12;259(5101):1622-5.

PMID:
8456286
47.

Functional antagonism between YY1 and the serum response factor.

Gualberto A, LePage D, Pons G, Mader SL, Park K, Atchison ML, Walsh K.

Mol Cell Biol. 1992 Sep;12(9):4209-14.

48.

PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.

Pongubala JM, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML.

Mol Cell Biol. 1992 Jan;12(1):368-78.

Supplemental Content

Loading ...
Support Center